Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.013 | 0.8 |